Vaccine containing the three allelic variants of the Plasmodium vivax circumsporozoite antigen induces protection in mice after challenge with a transgenic rodent Malaria parasite..
Plasmodium vivax is the most common species that cause malaria outside of the African continent. The development of an efficacious vaccine would contribute greatly to control malaria. Recently, using bacterial and adenoviral recombinant proteins based on the P. vivax circumsporozoite protein (CSP),...
Prif Awduron: | Gimenez, A, Lima, L, Françoso, K, Denapoli, P, Panatieri, R, Bargieri, D, Thiberge, J, Andolina, C, Nosten, F, Renia, L, Nussenzweig, R, Nussenzweig, V, Amino, R, Rodrigues, M, Soares, I |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Frontiers Media
2017
|
Eitemau Tebyg
-
Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite
gan: Alba Marina Gimenez, et al.
Cyhoeddwyd: (2017-10-01) -
Homologous and heterologous prime boost vaccinations with distinct variants of Plasmodium vivax circumsporozoite protein (CSP) protects mice against transgenic PB/PV sporozoite challenge
gan: Freitas, E, et al.
Cyhoeddwyd: (2017) -
Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
gan: de Camargo, T, et al.
Cyhoeddwyd: (2018) -
Exit of Plasmodium sporozoites from oocysts is an active process that involves the circumsporozoite protein.
gan: Qian Wang, et al.
Cyhoeddwyd: (2005-09-01) -
Protective Malaria Vaccine in Mice Based on the <i>Plasmodium vivax</i> Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein
gan: Rodolfo F. Marques, et al.
Cyhoeddwyd: (2020-04-01)